BGG463 is primarily utilized in the field of oncology research as a potent and selective inhibitor of specific kinases involved in cancer cell proliferation. Its application is significant in preclinical studies aimed at understanding the molecular mechanisms of tumor growth and identifying potential therapeutic targets. Researchers employ BGG463 to investigate its efficacy in suppressing kinase activity, which may lead to the development of novel anticancer drugs. Additionally, it is used in cellular assays to assess its impact on cancer cell lines, providing insights into its potential for inhibiting tumor progression. The compound’s ability to modulate kinase pathways makes it a valuable tool in the exploration of targeted cancer therapies.